This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Change to the manufacturing method of the positive control (pc) in the egfr rgq pcr kit. The change in manufacturing method includes an adjustment step of an in-process procedure to ensure that targeted amounts of each oligonucleotide within the pc are calculated to achieve the target crossing threshold (ct).
Device | THERASCREEN EGFR RGQ PCR KIT |
Classification Name | Somatic Gene Mutation Detection System |
Generic Name | Somatic Gene Mutation Detection System |
Applicant | QIAGEN MANCHESTER LTD |
Date Received | 2014-11-19 |
Decision Date | 2014-12-19 |
PMA | P120022 |
Supplement | S002 |
Product Code | OWD |
Advisory Committee | Pathology |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | QIAGEN MANCHESTER LTD skelton House lloyd Street North manchester M15 6 |
Supplement Number | Date | Supplement Type |
---|---|---|
P120022 | Original Filing | |
S022 | 2020-10-23 | Real-time Process |
S021 | 2020-03-04 | 30-day Notice |
S020 | 2019-08-28 | Special (immediate Track) |
S019 | 2018-03-08 | 30-day Notice |
S018 | 2018-02-16 | Normal 180 Day Track |
S017 | 2018-01-26 | 30-day Notice |
S016 | 2017-07-28 | Normal 180 Day Track |
S015 | 2017-06-29 | 30-day Notice |
S014 | 2016-12-28 | Normal 180 Day Track |
S013 | 2016-08-10 | 30-day Notice |
S012 | 2015-09-28 | Normal 180 Day Track No User Fee |
S011 | ||
S010 | 2015-02-18 | Normal 180 Day Track |
S009 | 2015-01-26 | Real-time Process |
S008 | 2015-01-26 | Real-time Process |
S007 | 2015-01-21 | 30-day Notice |
S006 | 2015-01-21 | 30-day Notice |
S005 | 2014-12-22 | 30-day Notice |
S004 | 2014-12-15 | 30-day Notice |
S003 | ||
S002 | 2014-11-19 | 30-day Notice |
S001 | 2014-09-18 | Normal 180 Day Track |